German Startups Group — Buying back shares

SGT German Private Equity (DB: SGF)

Last close As at 22/04/2024

1.22

0.01 (0.83%)

Market capitalisation

74m

More on this equity

Research: Financials

German Startups Group — Buying back shares

German Startups Group (GSG) continues its transformation into an asset manager. Within its existing portfolio, its focus is on successful exits with proceeds to be partially used for share buybacks and deleveraging. GSG is still exploring available options to exit Exozet, which visibly improved its financial performance in H119. We calculate that GSG’s current share price implies a 43% discount to NAV per share of €2.52 (at end June 2019, adjusted for subsequent buyback). Importantly, the NAV may be out of date as the revaluation of holdings is predominantly driven by new funding rounds/disposals, which were few in H119. Consequently, the average time elapsed since last revaluation based on third-party transactions in its portfolio stood at 357 days (end-June 2018: 226 days).

Milosz Papst

Written by

Milosz Papst

Director, Financials

Financials

German Startups Group

Buying back shares

Financials

Scale research report - Update

24 October 2019

Price

€1.44

Market cap

€16m

Share price graph

Share details

Code

GSJ

Listing

Deutsche Börse Scale

Shares in issue

10.9m

Last reported net debt at 30 June 2019

€8.3m

Business description

German Startups Group is a Berlin-based venture capital investment company primarily focused on providing investment to technology businesses in German-speaking countries. With the launch of its secondary shares trading platform, the company started the transition to a wider business model, including a marketplace.

Bull

NAV possibly understated.

Success of new business model may result in narrowing/closing the valuation gap to NAV and realising additional shareholder value.

Listed exposure to a diversified portfolio of technology start-ups in Germany.

Bear

Low liquidity.

VC investments are inherently high risk.

Potentially constrained by capital.

Analysts

Milosz Papst

+44 (0)20 3077 5700

Michal Mordel

+44 (0)20 3077 5700

German Startups Group (GSG) continues its transformation into an asset manager. Within its existing portfolio, its focus is on successful exits with proceeds to be partially used for share buybacks and deleveraging. GSG is still exploring available options to exit Exozet, which visibly improved its financial performance in H119. We calculate that GSG’s current share price implies a 43% discount to NAV per share of €2.52 (at end June 2019, adjusted for subsequent buyback). Importantly, the NAV may be out of date as the revaluation of holdings is predominantly driven by new funding rounds/disposals, which were few in H119. Consequently, the average time elapsed since last revaluation based on third-party transactions in its portfolio stood at 357 days (end-June 2018: 226 days).

Limited revaluations in the year to date

Both of GSG’s business segments were profitable in H119, although with limited revaluation triggers in the period, earnings were moderate. GSG reported basic EPS of €0.02 in H119 vs €0.14 in H118 and a loss of €0.05 in FY18. The investment business reported EBIT of €0.1m vs €1.9m in H118. At the same time, the only majority-held subsidiary, digital agency Exozet, improved its revenues (+38% y-o-y) and profitability, posting €0.9m EBIT (H118: €0.4m loss). During H119, GSG spent €0.5m on an investment in German Crypto Tech and follow-on funding for AuctionTech. Disposals generated €1.7m cash proceeds and included Chrono24, Service Partner One and Dalia Research.

Distributing capital to shareholders

GSG uses proceeds from disposals to perform buybacks and, since May 2018, has already bought back 9.4% (1.1m) of its total shares, with an average purchase price of €1.57. Most of the shares (900k) were acquired post the H119 reporting date for €1.50 each. We note that while distributions via buybacks are attractive for shareholders from a taxation perspective, they may limit the shares’ liquidity.

Valuation: Continues to trade at a discount to NAV

GSG’s current share price of €1.44 represents a 41% discount to NAV at end-H119 (based on the book value of equity ex-minorities), and 43% after accounting for post-reporting date share buyback (NAV per share of €2.52). Management expects H219 disposals to deliver significant cash proceeds and profit of at least half the market capitalisation, which was €15.1m at the time of the announcement.

Historical financials

Year
end

Revenue
(€m)

PBT
(€m)

EPS
(€)

DPS
(€)

P/E
(x)

Yield
(%)

12/15

5.6

3.6

0.49

0.0

2.9

N/A

12/16

10.9

(5.4)

(0.29)

0.0

N/A

N/A

12/17

9.6

1.8

0.14

0.0

10.6

N/A

12/18

12.5

1.2

(0.05)

0.0

N/A

N/A

Source: German Startups Group accounts

Edison Investment Research provides qualitative research coverage on companies in the Deutsche Börse Scale segment in accordance with section 36 subsection 3 of the General Terms and Conditions of Deutsche Börse AG for the Regulated Unofficial Market (Freiverkehr) on Frankfurter Wertpapierbörse (as of 1 March 2017). Two to three research reports will be produced per year. Research reports do not contain Edison analyst financial forecasts.

Financials: H119 a relatively quiet period

GSG’s basic EPS in H119 was €0.02 vs €0.14 in H118 and a loss of €0.05 in FY18. Taking into account possible future dilution from convertible bonds issued in 2018 (conversion price c 74% above the current share price and maturity in March 2023), the fully diluted EPS was €0.01 (vs €0.12 in H118). Both GSG’s business segments, Investments and Creative Technologies (Exozet), were profitable in the period. Majority-owned Exozet increased revenues by 38% y-o-y to €7.3m (in line with earlier guidance of more than 30% y-o-y) and posted EBIT of €0.9m, compared to a €0.4m loss in H118 (and €0.1m profit for the whole of FY18). Exozet made steady progress in new order intake, especially in the virtual/augmented reality segment, which grew ‘exceptionally fast and [was] profitable’, according to GSG. It is still considering (as announced in 2018) a disposal of its 50.7% stake in Exozet and is confident that the selling price would be significantly above acquisition costs and current book value.

Meanwhile, the result from GSG’s investments business stood at €0.7m in H119 vs €2.8m in H118, while segment EBIT amounted to €0.1m (H118: €1.9m). As a reminder, GSG invests in illiquid minority stakes in start-ups that are normally revalued upon new financing rounds or disposals, and there were few revaluation triggers in the period. The company segment revenues amounted to a minor €41k (up 32% y-o-y), and we believe they consisted mostly of fees generated by German Startups Market (GSM), its secondary start-ups/VC shares trading platform set up last year. Post balance sheet date, GSG announced a disposal of one portfolio company and a partial exit from another, with cash proceeds amounting to a mid-single-digit million-euro amount. The profit realised on the transactions was not disclosed though.

Exhibit 1: Results highlights

€000s

H119

H118

y-o-y

Profits from financial assets valued at fair value with recognition in profit or loss

1,470

4,081

-64%

Losses from financial assets valued at fair value with recognition in profit or loss

(818)

(1,379)

-41%

Result from investment business

653

2,777

-76%

Revenues

7,272

5,265

38%

Change in inventories

447

358

25%

Income from own work capitalised

233

294

-21%

Other operating income

168

90

87%

Cost of materials and services received

(1,670)

(1,560)

7%

Personnel expenses

(4,372)

(3,820)

14%

D&A

(491)

(340)

44%

Other operating expenses

(1,244)

(1,546)

-20%

Incidental acquisition costs of investments

(10)

(31)

-67%

Result from other components

333

(1,289)

N/A

EBIT

985

1,487

-34%

o/w Investments

59

1,873

-97%

o/w Creative Technologies

926

(386)

N/A

Interest income

15

16

-7%

Interest expense

(281)

(218)

29%

Net financial income

(266)

(202)

32%

EBT

719

1,285

-44%

Income taxes

(274)

136

N/A

Minorities adjustment

(260)

201

N/A

Net profit (ex-minorities)

184

1,622

-89%

EPS, basic (€)

0.02

0.14

-86%

Source: German Startups Group accounts

GSG continues to buy back its shares, with 900k shares (7.7% of the share count outstanding as at end-June 2019) bought back so far in H219 after repurchasing 200k shares in H218 (no shares were bought back in H119). As long as its share price remains significantly below reported NAV (with the current discount at c 43%), management will consider further buybacks as one of the means of recycling proceeds from portfolio exits.

Its net debt position remained stable at €8.3m in H119, implying a net debt/equity ratio of a comfortable 27% (H118: 25%). GSG highlights that its short-term financial assets (€2.2m in H119 vs €0.8m in H118) mainly include receivables from disposals. We cautiously do not include any short-term financial assets as cash-like items due to the lack of corresponding notes to the H119 accounts. As a comparison, we considered €0.5m out of €1.5m short-term financial assets at end-FY18 as liquid, cash-like items. We note that GSG’s actual leverage might turn out to be higher or lower if its minority stakes were reflected at current market values (which could influence equity value through profit/loss recognition). This is particularly important given that GSG’s asset revaluations were limited in recent months. The company’s liquidity was improved by disposals executed after the reporting date, with the proceeds mainly used for debt prepayment (€2.5m) and share buybacks (€1.4m).

GSG’s management expects positive developments in its FY19 results. In the Creative Technologies segment, on the back of good H119 results, GSG expects a c 20% y-o-y increase in revenues (implying H219 sales of c €7.7m, up 7% y-o-y). The focus here will be on improving profitability through a reduction of the costs of third-party services. In the investments segment, GSG expects FY19 gains on disposals to represent more than half of its market capitalisation (which stood at c €15m at the time of the announcement in August), which implies a c €7.5m profit on disposals. This includes transactions already concluded after the reporting date.

Portfolio development

At end-June 2019, GSG’s portfolio consisted of 31 companies, down from 33 at end-2018. Of these, 15 are considered of ‘particular significance’ in terms of size and potential, accounting for 86% of the total gross portfolio value of €26.5m. Three of those were subject to positive revaluations in H119. The top eight are considered ‘focus investments’ and make up 76% of the total portfolio value. During H119, GSG exited two companies that were not among its significant investments: Service Partner One (a provider of cloud-based software for facility management) and Dalia Research (an online-surveying provider). There was also a partial exit from the focus investment Chrono24 (reducing GSG’s stake from 2.1% at end-2018 to 1.2%). In cash terms, GSG invested €0.5m during H119 (mainly follow-on in AuctionTech), while disposals generated €1.7m proceeds.

Exhibit 2: GSG’s most significant portfolio components

Company

GSG’s stake at end H119

Change vs end-FY18

Book value*

Armedangels

2.8%

-

€20m

AuctionTech

23.4%

+2.3pp

Ceritech

8.8%

-

Chrono24

1.2%

-0.9pp

Fiagon

1.9%

-0.2pp

Mister Spex

1.3%

-

Remerge

2.4%

-

Simplesurance

1.6%

-

Customer Alliance

1.9%

-

€3m

Finiata

1.7%

-

Juniqe

1.7%

-

Onefootball

0.3%

-

SoundCloud

0.2%

-

Thinksurance

1.3%

N/A**

Wunder

0.4%

-0.1pp

Source: German Startups Group, Edison Investment Research. Note: *Edison Investment Research calculations. **Not in the most significant components at end-FY18.

Among portfolio companies, the most notable positive development was AuctionTech entering into a contract with Simon de Pury – a renowned auctioneers and founder of the world’s third-biggest auction house. The company will provide software for online transmissions of its auctions. Chrono24 closed its largest funding round so far in August 2019, raising €43m in new capital according to CrunchBase, with Sprints Capital as lead investor.

Slow but steady development of marketplace

As described in our previous note, GSG is transitioning to an asset manager and marketplace. As a first step in achieving this objective, in Q218 it set up German Startups Market (GSM), an online matchmaking platform for sellers and buyers of so-called secondary shares in German start-ups and VC funds. GSG aims to earn around 5% of the total volume traded on the platform in fees, which would deliver additional cash flow once trading on the platform reaches stable levels. Until 8 October 2019, over €3.5m worth of stakes was transacted on the platform and generated €150k in fee revenue (broadly in line with the intended effective fee). There are currently 14 investments available for sale listed on GSM, of which seven are (or were) among GSG’s most significant portfolio constituents. GSG also co-founded an asset-backed tokenization business German Crypto Tech, to launch one of the first German property-backed tokens.

Valuation

GSG’s NAV (ex-minorities but including goodwill and intangibles) was €28.7m at end-June 2019, translating into €2.44 per share (Edison estimate) vs €2.43 at end-2018. As mentioned above, GSG repurchased 900k shares (at an average price of €1.50 per share) after the reporting date. As a result, GSG currently holds 9.4% of its share count as treasury shares. Adjusting H119 reported NAV for the buyback and assuming no other changes, we calculate NAV per share of €2.52, with the current share price implying a c 43% discount. The company has not disclosed the impact on NAV of the post-balance sheet date disposals.

Moreover, the current NAV and discount are likely out of date, given that portfolio companies are mostly valued, where possible, by independent third-party transactions as described earlier in the note. At the end-June 2019, 81% of the total portfolio value was based on third-party valuations, with the average time elapsed since the last valuation of portfolio companies at 357 days (value weighted). Valuations of the remainder of the portfolio were altered to incorporate developments after the last third-party valuation date. Although the current discount to NAV is significant, we believe one of the reasons behind it may be the limited transparency of the performance of the portfolio companies, as GSG cannot disclose financial information on minority-held assets.

We also note that the company is a partnership limited by shares (KGaA), with the partner entitled to a preferential profit payment of 25% upon profitable disposals (which would reduce shareholder return). At end-2018, the possible profit advance (assuming the disposal of the whole portfolio at current book value) was €0.4m, or 3c per share.

In 2018 GSG issued €3m in convertible bonds, which could possibly result in future dilution. The bonds mature on 8 March 2023 and can be converted into 1.2m new shares at maturity with a conversion price of €2.50 per share (74% above the current share price). As the conversion price is close to current NAV per share, we calculate the fully diluted NAV per share at €2.52.


General disclaimer and copyright

Any Information, data, analysis and opinions contained in this report do not constitute investment advice by Deutsche Börse AG or the Frankfurter Wertpapierbörse. Any investment decision should be solely based on a securities offering document or another document containing all information required to make such an investment decision, including risk factors. This report has been commissioned by Deutsche Börse AG and prepared and issued by Edison for publication globally.

Edison Investment Research standard fees are £49,500 pa for the production and broad dissemination of a detailed note (Outlook) following by regular (typically quarterly) update notes. Fees are paid upfront in cash without recourse. Edison may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained in this report represent those of the research department of Edison at the time of publication. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Edison shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained on this note.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in the report may not be eligible for sale in all jurisdictions or to certain categories of investors.

Investment in securities mentioned: Edison has a restrictive policy relating to personal dealing and conflicts of interest. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report, subject to Edison's policies on personal dealing and conflicts of interest.

Copyright: Copyright 2019 Edison Investment Research Limited (Edison). All rights reserved FTSE International Limited (“FTSE”) © FTSE 2019. “FTSE®” is a trade mark of the London Stock Exchange Group companies and is used by FTSE International Limited under license. All rights in the FTSE indices and/or FTSE ratings vest in FTSE and/or its licensors. Neither FTSE nor its licensors accept any liability for any errors or omissions in the FTSE indices and/or FTSE ratings or underlying data. No further distribution of FTSE Data is permitted without FTSE’s express written consent.

Australia

Edison Investment Research Pty Ltd (Edison AU) is the Australian subsidiary of Edison. Edison AU is a Corporate Authorised Representative (1252501) of Crown Wealth Group Pty Ltd who holds an Australian Financial Services Licence (Number: 494274). This research is issued in Australia by Edison AU and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. Any advice given by Edison AU is general advice only and does not take into account your personal circumstances, needs or objectives. You should, before acting on this advice, consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If our advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument.

New Zealand

The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (i.e. without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision.

United Kingdom

This document is prepared and provided by Edison for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "FPO") (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document.

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States

The Investment Research is a publication distributed in the United States by Edison Investment Research, Inc. Edison Investment Research, Inc. is registered as an investment adviser with the Securities and Exchange Commission. Edison relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Edison does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

1,185 Avenue of the Americas

3rd Floor, New York, NY 10036

United States of America

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

1,185 Avenue of the Americas

3rd Floor, New York, NY 10036

United States of America

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

More on SGT German Private Equity

View All

Latest from the Financials sector

View All Financials content

Research: Healthcare

Mesoblast — Increasingly positive on aGvHD

With a positive primary endpoint plus 180-day data in acute graft versus host disease (aGvHD), Mesoblast is on track for its first US approval. Mesoblast is targeting US approval in H120 for GvHD and other key clinical trial endpoints, such as in Class II–III congestive heart failure (CHF) and lower back pain, and over the next two years is set to transition, assuming clinical and market success, into a profitable pharmaceutical company.

Continue Reading

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free